146 related articles for article (PubMed ID: 8828025)
1. Clinical efficacy of ebastine in the treatment and prevention of seasonal allergic rhinitis.
Peláez A
Drugs; 1996; 52 Suppl 1():35-8. PubMed ID: 8828025
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
Storms WW
Drugs; 1996; 52 Suppl 1():20-5. PubMed ID: 8828022
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
Gehanno P; Bremard-Oury C; Zeisser P
Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
[TBL] [Abstract][Full Text] [Related]
4. A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients.
Ankier SI; Warrington SJ
J Intern Med; 1989 Dec; 226(6):453-8. PubMed ID: 2577377
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
Ratner PH; Lim JC; Georges GC
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
[TBL] [Abstract][Full Text] [Related]
6. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
[TBL] [Abstract][Full Text] [Related]
7. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
Wiseman LR; Faulds D
Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
[TBL] [Abstract][Full Text] [Related]
8. Comparative clinical studies with ebastine: efficacy and tolerability.
Luria X
Drug Saf; 1999; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis.
Frank H; Gillen M; Rohatagi SS; Lim J; George G;
J Clin Pharmacol; 2002 Oct; 42(10):1097-104. PubMed ID: 12362923
[TBL] [Abstract][Full Text] [Related]
10. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
Hampel F; Howland W; Van Bavel J; Ratner P
J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Ratner P; Hampel F; Van Bavel J; Howland W
Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
[TBL] [Abstract][Full Text] [Related]
13. [Ebastine vs terfenadine in allergic rhinitis].
Terán Ortíz L; Flores Sandoval G; Orea Solano M; Camarena A
Rev Alerg; 1993; 40(4):82-5. PubMed ID: 7908244
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
Ratner P; Falqués M; Chuecos F; Esbrí R; Gispert J; Peris F; Luria X; Rosales MJ
Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195
[TBL] [Abstract][Full Text] [Related]
15. [Effects of double-dose antihistamine or combined therapy in allergic rhinitis].
Li LS; Guan K; Cui L; Wang RQ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(1):27-32. PubMed ID: 29798206
[No Abstract] [Full Text] [Related]
16. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
[TBL] [Abstract][Full Text] [Related]
17. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
Kalis B
Drugs; 1996; 52 Suppl 1():30-4. PubMed ID: 8828024
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
Murris-Espin M; Melac M; Charpentier JC; Didier A
Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
[TBL] [Abstract][Full Text] [Related]
19. Ebastine: an update of its use in allergic disorders.
Hurst M; Spencer CM
Drugs; 2000 Apr; 59(4):981-1006. PubMed ID: 10804044
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of ebastine 10mg and 20mg once daily with that of cetirizine 10mg once daily in adults with seasonal allergic rhinitis. A multicentre double-blind study.
Cohen B; Gehanno P
Drugs; 1996; 52 Suppl 1():26-9. PubMed ID: 8828023
[No Abstract] [Full Text] [Related]
[Next] [New Search]